楼主: cbchinese
26640 65

[词条] 样本量计算详解与指导PASS手册下载   [推广有奖]

  • 6关注
  • 23粉丝

已卖:5364份资源

讲师

73%

还不是VIP/贵宾

-

威望
0
论坛币
19393 个
通用积分
536.1343
学术水平
31 点
热心指数
47 点
信用等级
38 点
经验
8241 点
帖子
569
精华
0
在线时间
210 小时
注册时间
2009-5-20
最后登录
2022-2-22

楼主
cbchinese 发表于 2013-3-12 18:47:30 |AI写论文

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
PASS11帮助手册绝对是学习计算样本量最好的材料,它不仅仅是帮助如何使用PASS,更从理论等各方面详细说明了样本量计算的方法,过程,如果想学习样本量计算,大家可以下载。
简单向在家举个例子,在临床随机对照试验时,我们要采用非劣效试验,那么如何计算非劣效试验的样本量呢?
下面看本手册里的具体分析:
在Survival analysis下的logrank tests for non-inferiority下查看内容如下:

Introduction
This module computes the sample size and power for non-inferiority tests under the assumption
of proportional hazards. Accrual time and follow-up time are included among the parameters to
be set. The non-inferiority logrank test is used for data analysis.
Sometimes, the objective of a study is to show that an experimental therapy is not inferior to (no
worse than) the standard therapy. The experimental therapy may be cheaper, less toxic, or have
fewer side effects. Such studies are often called non-inferiority trials and have a one-sided
hypothesis.
Power and sample size calculations for the non-inferiority logrank test have been developed by
Jung et al. (2005), and we use their results. These calculations assume an underlying exponential
survival distribution with a uniform patient accrual pattern during the accrual period.

Technical Details
Test Statistic
Suppose a clinical trial consists of two independent groups. Designate group one as the standard
group with hazard rate h1 and sample size n1. Designate group two as the experimental group with
hazard rate h2 and sample size n2. The total sample size is N = n1+n2 . Usually, you would plan
to have n1=n2 .
Define the proportion of the total sample in each group as
Qi = ni/N, i=1,2
Individuals are recruited during an accrual period of R years (or months or days). They are
followed for an additional period of time until a total of T years is reached. Hence, the follow-up
period is T-R years. At the end of the study, the non-inferiority logrank test is conducted at
significance level α with power 1− β . Under the proportion hazards assumption, the hazard
ratio HR = h2 / h1 is constant across time.
For a given non-inferiority margin HR0 (>1) (the maximum ratio of clinical insignificance), the
statistical hypotheses tested are
H0 : HR ≥ HR0 vs. H1 : HR < HR0
.......
实际它把所有的计算过程都很详细的写了出来。

本帖隐藏的内容

NCSS_PASS 11使用手册.pdf (31.19 MB, 需要: 2 个论坛币)




二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:Pass 样本量 pas Experimental significance 指导 计算 下载 如何 最好

PASS 11举例_页面_2.jpg (258.33 KB)

PASS 11举例_页面_2.jpg

PASS 11举例_页面_1.jpg (272.58 KB)

PASS 11举例_页面_1.jpg

沙发
cbchinese(未真实交易用户) 发表于 2013-3-14 23:08:28
希望对大家有点儿用

藤椅
yueqing0909(真实交易用户) 发表于 2013-3-21 00:28:03
kkzy

板凳
jswu167(未真实交易用户) 企业认证  发表于 2013-3-22 09:33:34
找几人把翻译出来,我算一个

报纸
mssr(未真实交易用户) 发表于 2013-3-22 21:37:40
may see that

地板
cbchinese(未真实交易用户) 发表于 2013-3-23 08:02:48
jswu167 发表于 2013-3-22 09:33
找几人把翻译出来,我算一个
嘻嘻,兄弟也想啊,但这个很麻烦,需要先申请版权啊。我们先凑合看着吧

7
rdzr(真实交易用户) 发表于 2013-3-25 20:55:12
好书,期待!

8
rdzr(真实交易用户) 发表于 2013-3-25 21:12:08
LZ还算厚道!

9
biostat(真实交易用户) 发表于 2013-4-5 17:49:50
看看是否能用的上

10
biostat(真实交易用户) 发表于 2013-4-5 18:04:08
是软件自带的。没必要

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
加好友,备注jltj
拉您入交流群
GMT+8, 2025-12-9 10:15